metformin has been researched along with Osteonecrosis in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Osteonecrosis: Death of a bone or part of a bone, either atraumatic or posttraumatic.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Tang, B | 1 |
Chen, Y | 1 |
Zhao, P | 1 |
Yan, W | 1 |
Huang, X | 1 |
Jiang, W | 1 |
Sun, M | 1 |
Zhang, H | 1 |
Xiang, D | 1 |
Chen, T | 1 |
Lian, C | 1 |
Zhang, J | 1 |
Park, SH | 1 |
Kang, MA | 1 |
Moon, YJ | 1 |
Jang, KY | 1 |
Kim, JR | 1 |
Kotler, DP | 1 |
3 other studies available for metformin and Osteonecrosis
Article | Year |
---|---|
MiR-601-induced BMSCs senescence accelerates steroid-induced osteonecrosis of the femoral head progression by targeting SIRT1.
Topics: Animals; Femur Head; Glucocorticoids; Hydrogen Peroxide; Mesenchymal Stem Cells; Metformin; MicroRNA | 2023 |
Metformin coordinates osteoblast/osteoclast differentiation associated with ischemic osteonecrosis.
Topics: Angiogenesis Inducing Agents; Angiopoietin-1; Animals; Cell Differentiation; Cell Line, Tumor; Femur | 2020 |
Metabolic alterations in HIV lipodystrophy. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
Topics: Acidosis; Anti-HIV Agents; Bone Diseases, Metabolic; Cost-Benefit Analysis; Glucose; Glucose Intoler | 2001 |